nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—VCAM1—tunica intima—abdominal aortic aneurysm	0.0757	0.156	CbGeAlD
Carvedilol—NPPB—artery—abdominal aortic aneurysm	0.0417	0.0858	CbGeAlD
Carvedilol—NPPB—blood plasma—abdominal aortic aneurysm	0.0313	0.0644	CbGeAlD
Carvedilol—SELE—artery—abdominal aortic aneurysm	0.0282	0.058	CbGeAlD
Carvedilol—VCAM1—artery—abdominal aortic aneurysm	0.0259	0.0533	CbGeAlD
Carvedilol—HIF1A—artery—abdominal aortic aneurysm	0.0249	0.0513	CbGeAlD
Carvedilol—GJA1—artery—abdominal aortic aneurysm	0.0242	0.0498	CbGeAlD
Carvedilol—SELE—blood plasma—abdominal aortic aneurysm	0.0211	0.0435	CbGeAlD
Carvedilol—VCAM1—blood plasma—abdominal aortic aneurysm	0.0194	0.04	CbGeAlD
Carvedilol—SELE—connective tissue—abdominal aortic aneurysm	0.0113	0.0232	CbGeAlD
Carvedilol—VCAM1—connective tissue—abdominal aortic aneurysm	0.0104	0.0213	CbGeAlD
Carvedilol—HIF1A—connective tissue—abdominal aortic aneurysm	0.00996	0.0205	CbGeAlD
Carvedilol—GJA1—connective tissue—abdominal aortic aneurysm	0.00966	0.0199	CbGeAlD
Carvedilol—ADRB3—connective tissue—abdominal aortic aneurysm	0.00886	0.0182	CbGeAlD
Carvedilol—VCAM1—kidney—abdominal aortic aneurysm	0.00881	0.0181	CbGeAlD
Carvedilol—HIF1A—kidney—abdominal aortic aneurysm	0.00848	0.0174	CbGeAlD
Carvedilol—GJA1—kidney—abdominal aortic aneurysm	0.00823	0.0169	CbGeAlD
Carvedilol—SELE—spinal cord—abdominal aortic aneurysm	0.00746	0.0153	CbGeAlD
Carvedilol—NDUFC2—kidney—abdominal aortic aneurysm	0.00716	0.0147	CbGeAlD
Carvedilol—VCAM1—spinal cord—abdominal aortic aneurysm	0.00686	0.0141	CbGeAlD
Carvedilol—HIF1A—spinal cord—abdominal aortic aneurysm	0.0066	0.0136	CbGeAlD
Carvedilol—GJA1—spinal cord—abdominal aortic aneurysm	0.00641	0.0132	CbGeAlD
Carvedilol—XDH—kidney—abdominal aortic aneurysm	0.00578	0.0119	CbGeAlD
Carvedilol—NDUFC2—spinal cord—abdominal aortic aneurysm	0.00558	0.0115	CbGeAlD
Carvedilol—PTGS1—artery—abdominal aortic aneurysm	0.00514	0.0106	CbGeAlD
Carvedilol—VEGFA—spinal cord—abdominal aortic aneurysm	0.00506	0.0104	CbGeAlD
Carvedilol—CYP1A2—blood plasma—abdominal aortic aneurysm	0.00445	0.00915	CbGeAlD
Carvedilol—ADRA1B—kidney—abdominal aortic aneurysm	0.00434	0.00892	CbGeAlD
Carvedilol—CYP2C9—blood plasma—abdominal aortic aneurysm	0.00422	0.00868	CbGeAlD
Carvedilol—ADRA2A—blood plasma—abdominal aortic aneurysm	0.00409	0.00841	CbGeAlD
Carvedilol—CYP2E1—blood plasma—abdominal aortic aneurysm	0.004	0.00823	CbGeAlD
Carvedilol—PTGS1—blood plasma—abdominal aortic aneurysm	0.00385	0.00793	CbGeAlD
Carvedilol—ADRB1—connective tissue—abdominal aortic aneurysm	0.00362	0.00745	CbGeAlD
Carvedilol—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00322	0.00662	CbGeAlD
Carvedilol—CYP2D6—blood plasma—abdominal aortic aneurysm	0.00317	0.00651	CbGeAlD
Carvedilol—ADRA2C—kidney—abdominal aortic aneurysm	0.00232	0.00478	CbGeAlD
Carvedilol—ABCB1—blood plasma—abdominal aortic aneurysm	0.00228	0.00469	CbGeAlD
Carvedilol—ADRA2A—connective tissue—abdominal aortic aneurysm	0.00218	0.00448	CbGeAlD
Carvedilol—PTGS1—connective tissue—abdominal aortic aneurysm	0.00205	0.00422	CbGeAlD
Carvedilol—CYP1A1—kidney—abdominal aortic aneurysm	0.00199	0.00409	CbGeAlD
Carvedilol—KCNH2—spinal cord—abdominal aortic aneurysm	0.00183	0.00377	CbGeAlD
Carvedilol—CYP2E1—kidney—abdominal aortic aneurysm	0.00181	0.00373	CbGeAlD
Carvedilol—ADRA2C—spinal cord—abdominal aortic aneurysm	0.00181	0.00372	CbGeAlD
Carvedilol—PTGS1—kidney—abdominal aortic aneurysm	0.00175	0.00359	CbGeAlD
Carvedilol—CYP3A4—kidney—abdominal aortic aneurysm	0.00146	0.003	CbGeAlD
Carvedilol—ADRA2A—spinal cord—abdominal aortic aneurysm	0.00144	0.00297	CbGeAlD
Carvedilol—CYP2D6—kidney—abdominal aortic aneurysm	0.00144	0.00295	CbGeAlD
Carvedilol—CYP2E1—spinal cord—abdominal aortic aneurysm	0.00141	0.0029	CbGeAlD
Carvedilol—PTGS1—spinal cord—abdominal aortic aneurysm	0.00136	0.0028	CbGeAlD
Carvedilol—ABCB1—kidney—abdominal aortic aneurysm	0.00103	0.00212	CbGeAlD
Carvedilol—ABCB1—spinal cord—abdominal aortic aneurysm	0.000804	0.00165	CbGeAlD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000211	0.000411	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00021	0.00041	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000209	0.000406	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.0002	0.00039	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000199	0.000387	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000197	0.000383	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000196	0.000382	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000195	0.00038	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—NOS2—abdominal aortic aneurysm	0.000195	0.00038	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000194	0.000378	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000194	0.000377	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000193	0.000376	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000192	0.000374	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00019	0.000369	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000187	0.000365	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000184	0.000358	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000183	0.000355	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—NOS2—abdominal aortic aneurysm	0.000182	0.000355	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000181	0.000353	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000181	0.000353	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000181	0.000352	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000181	0.000352	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.00018	0.000351	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000179	0.000349	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000179	0.000348	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000178	0.000346	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000177	0.000343	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000176	0.000342	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AAAS—abdominal aortic aneurysm	0.000175	0.000341	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AAAS—abdominal aortic aneurysm	0.000175	0.000341	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000175	0.000341	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000175	0.00034	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000174	0.000339	CbGpPWpGaD
Carvedilol—XDH—Metabolism—AGT—abdominal aortic aneurysm	0.000173	0.000336	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000172	0.000335	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000172	0.000335	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000172	0.000334	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000171	0.000332	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000169	0.000329	CbGpPWpGaD
Carvedilol—XDH—Metabolism—APOE—abdominal aortic aneurysm	0.000169	0.000329	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000169	0.000329	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000168	0.000327	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000167	0.000325	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000166	0.000324	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000166	0.000323	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000164	0.00032	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000164	0.000319	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000163	0.000317	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000161	0.000313	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00016	0.000312	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000158	0.000308	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000157	0.000305	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000157	0.000305	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000156	0.000304	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000156	0.000303	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000156	0.000303	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000155	0.000302	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000154	0.0003	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000154	0.000299	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000153	0.000299	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—LDLR—abdominal aortic aneurysm	0.000153	0.000298	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—LDLR—abdominal aortic aneurysm	0.000153	0.000298	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000152	0.000296	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00015	0.000291	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000149	0.000291	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—NOS2—abdominal aortic aneurysm	0.000148	0.000288	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000148	0.000288	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000146	0.000283	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000145	0.000282	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000143	0.000278	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AAAS—abdominal aortic aneurysm	0.000143	0.000277	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000142	0.000277	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000142	0.000277	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000142	0.000276	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000138	0.000269	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000138	0.000269	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000137	0.000267	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000137	0.000267	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000136	0.000265	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000136	0.000264	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000135	0.000263	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000135	0.000263	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000133	0.00026	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000132	0.000257	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AAAS—abdominal aortic aneurysm	0.000131	0.000255	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000129	0.000252	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000128	0.00025	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000128	0.00025	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000128	0.000249	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000128	0.000249	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000127	0.000247	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000127	0.000246	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000126	0.000246	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000126	0.000245	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000125	0.000244	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000125	0.000243	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—LDLR—abdominal aortic aneurysm	0.000124	0.000242	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000124	0.000242	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000124	0.000241	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AAAS—abdominal aortic aneurysm	0.000123	0.00024	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000123	0.00024	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000123	0.000239	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000123	0.000239	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000122	0.000237	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000121	0.000236	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000121	0.000235	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00012	0.000234	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00012	0.000233	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000118	0.000229	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000118	0.000229	CbGpPWpGaD
Carvedilol—XDH—Metabolism—PTGS2—abdominal aortic aneurysm	0.000116	0.000226	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000115	0.000223	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—LDLR—abdominal aortic aneurysm	0.000114	0.000222	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000114	0.000222	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000113	0.000219	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000112	0.000218	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000112	0.000218	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00011	0.000215	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—LDLR—abdominal aortic aneurysm	0.000108	0.00021	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000105	0.000204	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000104	0.000202	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000104	0.000202	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000103	0.0002	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000103	0.000199	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000102	0.000198	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000102	0.000198	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000102	0.000198	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000101	0.000198	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000101	0.000197	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000101	0.000197	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.0001	0.000195	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	9.98e-05	0.000194	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	9.86e-05	0.000192	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NCF1—abdominal aortic aneurysm	9.73e-05	0.000189	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AGTR1—abdominal aortic aneurysm	9.62e-05	0.000187	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	9.54e-05	0.000186	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	9.47e-05	0.000184	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AGTR1—abdominal aortic aneurysm	9.47e-05	0.000184	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	9.45e-05	0.000184	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CCL2—abdominal aortic aneurysm	9.44e-05	0.000184	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	9.35e-05	0.000182	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AGT—abdominal aortic aneurysm	9.31e-05	0.000181	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CCL2—abdominal aortic aneurysm	9.29e-05	0.000181	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	9.29e-05	0.000181	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP3—abdominal aortic aneurysm	9.26e-05	0.00018	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	9.21e-05	0.000179	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP3—abdominal aortic aneurysm	9.18e-05	0.000179	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP3—abdominal aortic aneurysm	9.06e-05	0.000176	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	8.6e-05	0.000167	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	8.58e-05	0.000167	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP3—abdominal aortic aneurysm	8.57e-05	0.000167	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP3—abdominal aortic aneurysm	8.44e-05	0.000164	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	8.41e-05	0.000164	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CCL2—abdominal aortic aneurysm	8.25e-05	0.000161	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	8.15e-05	0.000159	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	8.11e-05	0.000158	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AGT—abdominal aortic aneurysm	8.1e-05	0.000158	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AGT—abdominal aortic aneurysm	8.08e-05	0.000157	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	8.04e-05	0.000156	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AGT—abdominal aortic aneurysm	8.03e-05	0.000156	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	7.99e-05	0.000155	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—APOE—abdominal aortic aneurysm	7.93e-05	0.000154	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—APOE—abdominal aortic aneurysm	7.92e-05	0.000154	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AAAS—abdominal aortic aneurysm	7.87e-05	0.000153	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—APOE—abdominal aortic aneurysm	7.87e-05	0.000153	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	7.81e-05	0.000152	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CCL2—abdominal aortic aneurysm	7.67e-05	0.000149	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP3—abdominal aortic aneurysm	7.5e-05	0.000146	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AGT—abdominal aortic aneurysm	7.31e-05	0.000142	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.26e-05	0.000141	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AGT—abdominal aortic aneurysm	7.25e-05	0.000141	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.24e-05	0.000141	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.18e-05	0.00014	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—APOE—abdominal aortic aneurysm	7.17e-05	0.000139	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.17e-05	0.000139	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AGT—abdominal aortic aneurysm	7.15e-05	0.000139	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—APOE—abdominal aortic aneurysm	7.1e-05	0.000138	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—APOE—abdominal aortic aneurysm	7.01e-05	0.000136	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP3—abdominal aortic aneurysm	6.96e-05	0.000136	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—LDLR—abdominal aortic aneurysm	6.87e-05	0.000134	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AGT—abdominal aortic aneurysm	6.77e-05	0.000132	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AGT—abdominal aortic aneurysm	6.66e-05	0.00013	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—APOE—abdominal aortic aneurysm	6.63e-05	0.000129	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCL2—abdominal aortic aneurysm	6.61e-05	0.000129	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AGT—abdominal aortic aneurysm	6.58e-05	0.000128	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—APOE—abdominal aortic aneurysm	6.53e-05	0.000127	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APOE—abdominal aortic aneurysm	6.44e-05	0.000125	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	6.4e-05	0.000125	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	6.17e-05	0.00012	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	6.07e-05	0.000118	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AGT—abdominal aortic aneurysm	6.04e-05	0.000118	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCL2—abdominal aortic aneurysm	6.02e-05	0.000117	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.97e-05	0.000116	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AGT—abdominal aortic aneurysm	5.92e-05	0.000115	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOE—abdominal aortic aneurysm	5.92e-05	0.000115	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.89e-05	0.000115	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOE—abdominal aortic aneurysm	5.8e-05	0.000113	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AGT—abdominal aortic aneurysm	5.69e-05	0.000111	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.62e-05	0.000109	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOE—abdominal aortic aneurysm	5.58e-05	0.000109	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.58e-05	0.000109	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.57e-05	0.000108	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.5e-05	0.000107	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AGT—abdominal aortic aneurysm	5.5e-05	0.000107	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.49e-05	0.000107	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	5.47e-05	0.000107	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTGS2—abdominal aortic aneurysm	5.44e-05	0.000106	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTGS2—abdominal aortic aneurysm	5.43e-05	0.000106	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOE—abdominal aortic aneurysm	5.39e-05	0.000105	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	5.3e-05	0.000103	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.21e-05	0.000101	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.12e-05	9.97e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCL2—abdominal aortic aneurysm	4.87e-05	9.49e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.73e-05	9.2e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.68e-05	9.1e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.55e-05	8.86e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	4.55e-05	8.85e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCL2—abdominal aortic aneurysm	4.53e-05	8.81e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	4.46e-05	8.67e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—abdominal aortic aneurysm	4.42e-05	8.59e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.31e-05	8.38e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	4.29e-05	8.34e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.27e-05	8.31e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.26e-05	8.29e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	4.25e-05	8.27e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.23e-05	8.23e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.22e-05	8.22e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.21e-05	8.2e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	4.2e-05	8.17e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.17e-05	8.11e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	4.16e-05	8.1e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—abdominal aortic aneurysm	4.05e-05	7.89e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.99e-05	7.76e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.94e-05	7.68e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.92e-05	7.64e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.88e-05	7.56e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—abdominal aortic aneurysm	3.82e-05	7.44e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AGT—abdominal aortic aneurysm	3.63e-05	7.06e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOE—abdominal aortic aneurysm	3.56e-05	6.92e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.49e-05	6.78e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.45e-05	6.71e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.24e-05	6.3e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.2e-05	6.24e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	3.05e-05	5.94e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	2.88e-05	5.6e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	2.85e-05	5.55e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	2.8e-05	5.45e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	2.75e-05	5.34e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—abdominal aortic aneurysm	2.44e-05	4.74e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	1.88e-05	3.66e-05	CbGpPWpGaD
